NCT02231008View on ClinicalTrials.gov

Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 19, 2018

Study Completion Date

January 31, 2022

Conditions
Smith-Magenis SyndromeCircadian
Interventions
DRUG

tasimelteon

DRUG

placebo

Trial Locations (4)

Unknown

Santa Monica

Baltimore

Chevy Chase

Houston

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY